Global Spine Congress 2017 Calendar

EVENTS

by Trafas Administrator

GS Medical USA Experiences Growth, Expansion and New Product Development in 2015

James Shin, CEO of GS America summarized, “2015 was a very successful year for GSM. Not only were we able to add significant resources to our R&D teams in the way of technology, machinery and team members, we were also awarded two new patents and FDA clearance for several innovative products. In addition to our R&D teams, we have made tremendous advancements with talented leadership and in our quality, operations and sales teams.”

“People are the focus of our attention,” explained Brian Oliver, VP of Sales and Marketing, “and we must first concentrate on the well-being of patients and customers. Our priority remains finding solutions to improve the care of patients while delivering impeccable service and technology to our surgeons and distributors. I am very pleased with the progress and growth within GSM during the past year. Our surgeons and distributors continue to speak highly of their interactions and relationships with GSM, and this is only the beginning!” The company is also thrilled to announce the launch of a new website, which will serve as a platform to continue to provide customers with real time information about the growth and development of GSM.

With investments in sales, R&D, engineering and marketing, GSM has laid a solid foundation from which to propel sales and revenue forward in 2016. Through partnerships with local and national GPOs and IDNs, GSM will continue to bring quality, value and cost-conscious solutions to hospitals, surgery centers and patients. “Having the conversation with our surgeons and hospitals about the breadth of treatment options that are available in the care of spine maladies is very rewarding.” states Heather Cain, Clinical Resource Manger. “The greatest reward is when we as a comprehensive patient care team can identify procedural, product and economic solutions to help our customer meet their economic goals.”

The vision for GSM in 2016 is clear: more solutions for new product, value and quality to the surgeon and hospital, and continued growth and expansion via distribution, partnership, and education on the sales front. With the new year well underway, GSM will continue to remain committed to excellence in all aspects of its mission and vision.
About GS Medical USA, LLC

GS Medical USA features many spinal products spanning lumbar, thoracic, and launching new cervical applications. GSM products have been used in thousands of spine surgeries throughout the USA, and hundreds of thousands globally. Staffed with a network of industry leaders, medical sales distributors, engineers, and collaborating physicians, GSM is at the forefront of high-quality, value-added medical technology with a number of innovative implant solutions in the commercialization pipeline. Corporate headquarters are in Irvine, California and with international offices located in Seoul, Korea.

by Trafas Administrator

J&J's DePuy to End 2 Hip Replacement System

Johnson & Johnson's DePuy orthopedics business plans to stop selling a couple of hip replacement systems not widely used by doctors.

DePuy will discontinue both its Ultamet Metal-on-Metal Articulation and Complete Ceramic-on-Metal Acetabular systems worldwide at the end of August. It made the decision as part of a push to streamline its product portfolio. DePuy said Thursday the discontinuations were not connected to concerns about safety or effectiveness, and they were not recalls.

J&J, based in New Brunswick, N.J., has been hampered by an embarrassing spate of product recalls of artificial joints, contact lenses, prescription drugs and over-the-counter medicines that began in 2009. DePuy recalled two artificial joint systems — the ASR Hip Resurfacing System and the ASR XL Acetabular System — in 2010 because of unexpectedly high failure rates.

DePuy said the Ultamet and Complete brands now represent less than 1 percent of its bearings sold in the United States and Europe. Physicians have come to prefer metal-on-polyethylene, ceramic-on-polyethylene and ceramic-on-ceramic bearings. Polyethylene is a medical-grade form of plastic.

The company said it also made its decision due to proposed Food and Drug Administration changes that would require a more extensive approval process for metal-on-metal systems. Ultamet is DePuy's only metal-on-metal system, and the company noted that clinical demand for this type of hip replacement is extremely low.

Artificial joint systems replace deteriorated joints causing severe pain and limiting mobility. Hip replacement parts include the top of the thigh bone, the ball atop that and a plate lining the hip socket. The systems are generally expected to last at least 10 to 20 years.

DePuy said it will announce other worldwide product discontinuations this year and next, as it simplifies its portfolio.

Shares of J&J climbed 19 cents to $87.64 in midday trading, while broader trading indexes also rose less than 1 percent. The stock reached a new, 52-week high price of $88.07 earlier in the morning, and J&J shares have climbed about 25 percent so far this year.

by Trafas Administrator

First "handshake" between Chinese and Russian General Military Hospital

On March 2, 2015, the orthopaedic experts from Russian General Military Hospital visited General Hospital of the People's Liberation Army (PLAGH), the biggest military general hospital in China, and had an in-depth academic change with Chinese experts in Beijing, China.

At 9 a.m., EVGENY VLADIMIROVICH KRYUKOV ( President of Russian General Military Hospital) led LEONID KARLOVICH BRIZHA ( Dean of trauma and orthopaedic hospital center), DENIS VLADIMIROVICH DAVYDOV ( Medicine surgical professor of medical scientific research institute of affiliated defense department) and SERGEY NIKOLAEVICH PEREKHODOV ( Russia exploits doctor, a senior surgeon) visited PLAGH for academic exchange. Directors of Orthopaedic Dept., Spine Dept., Joint Dept. and Trauma Dept. expressed warm welcome and showed them around and gave detailed introduction of the hospital.
 
After visiting the hospital, Chinese and Russian orthopedic experts had a lively cross-border medical seminar in both English and Russian. The two top countries orthopedic experts had a colorful and vivid academic exchange and experience report under orthopedic and trauma emergency topic.
At the end of the seminar, both sides reached a preliminary cooperation agreement on exchange program of young doctors of the two countries. There is no doubt that this handshake between the top hospitals is a milestone in the history of orthopaedic academic development between China and Russia. And we can expect further cooperation in near future.

by Trafas Administrator

ZIMMER KNEE RECALL

Zimmer Recalls NexGen Knee Replacement Component Due to Risk of Failure - Zimmer NexGen Knee Failure Rate May Be Unusually High - Lawyers Offer Free Zimmer NexGen Knee Case Review.

Zimmer, Inc., the maker of artificial joint replacement systems, recently announced the recall of more than 65,000 NexGen MIS tibial knee replacement components after studies showed that it loosened, causing pain and discomfort and ultimately required additional surgery to replace the failing Zimmer NexGen knee.

Prominent joint replacement surgeons, including one of Zimmer's most highly regarded former orthopedic surgeon consultants, have issued stern warnings about the long-term viability of select Zimmer NexGen knee replacement systems. Major publications have reported on multiple medical studies by different orthopedic surgeons for different Zimmer NexGen knee replacement systems that show an unacceptably high number become loose at the femoral component and require revision surgery to be corrected. While most of the Zimmer NexGen knee replacement systems are not experiencing problems, other are - both those recalled & those not recalled.

This website contains information about the Zimmer knee recall and claims you or a loved one may make if you have a Zimmer NexGen knee replacement system that has loosened or is otherwise causing you pain and/or a decrease in mobility.

by Trafas Administrator

Wontech Host Symposia W in Seoul

Wontech, a leading innovator of aesthetic and medical advanced laser and related technology, took place a special meeting “Symposia W” at Chrysanthemum Room of Seoul Grand Intercontinental Hotel on 3rd of September, 2016. “Symposia W” is periodical event which host more than 2 times a year, including to place in domestic and international region. In the symposium, there are plenty of remarkable clinical issues with the evidences among reputational dermatologists, and it’s a good meeting to share their own experiences and consultation. 

The WonTech’s 'Symposia W' theme is "Beyond the Nano, into the Pico, present and future of the long-pulse laser". Lecture programs are ▲ 'What is Pico laser?, Clinical application of PICOCARE' by Dr. Yeo Euncheol, director of Jongro S & U dermatology clinic ▲ ‘Preclinical studies of PICOCARE’s color tattoo apply’ by Dr. An Jincheol, pre-med chairman of Dankook University ▲ ‘1064nm & 1320nm Mercury Laser experience’ by Dr. Seo Seokbae, director of SeoAhSong dermatology clinic. Dr. Park GiBeon, director of Seoul dermatology clinic was anchored as a facilitator. This seminar was focused clinical studies and application plan of WonTech’s representative equipment PICOCARE.

 

WonTech’s representative equipment 'PICOCARE’ is newest device which can be delivers laser energy with 1,000 times shorter than conventional Nanosecond laser that minimize the damage of skin and destroy various pigment at the same time. It approved KFDA last May and getting a lot of attention from domestic and overseas because of better functions and performance to compare with the world's top brands devices. Currently, famous dermatology clinics such as SeoAhSong dermatology clinic, WeedWin dermatology clinics and others use PICOCARE.

A president of Wontech, Mr. Jong won Kim had announced that “Symposia W” was hosted by sharing and discussion of valuable clinical information, and Wontech keep having a plan to host a meeting to the users throughout varied programs.

by Trafas Administrator